
CRISPR Therapeutics AG (NASDAQ:CRSP) is trending Thursday, up more than 45% over the past month. Here’s a look at what’s driving the move.
What To Know: In late June, the company reported new early-stage data showing its experimental treatment CTX310 significantly lowered triglycerides and LDL cholesterol in patients, with no major safety issues. CRISPR Therapeutics said it plans to share full results in late 2025.